Cellosaurus Hep-G2 VL-17A (CVCL_A5CT)
Cell line name | Hep-G2 VL-17A |
---|---|
Synonyms | HepG2 VL-17A; VL-17A; VL17A |
Accession | CVCL_A5CT |
Resource Identification Initiative | To cite this cell line use: Hep-G2 VL-17A (RRID:CVCL_A5CT) |
Comments | Population: Caucasian. Genetic integration: Method=Transfection/transduction; Gene=HGNC; 2631; CYP2E1. Genetic integration: Method=Transfection/transduction; Gene=MGI; MGI:87921; Adh1. Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Transposon Tn5 neo. Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR). Derived from site: In situ; Liver; UBERON=UBERON_0002107. |
Sequence variations |
|
Disease | Hepatoblastoma (NCIt: C3728) Hepatoblastoma (ORDO: Orphanet_449) |
Species of origin | Homo sapiens (Human) (NCBI Taxonomy: 9606) |
Hierarchy | Parent: CVCL_A5CQ (Hep-G2 VA-13) |
Sex of cell | Male |
Age at sampling | 15Y |
Category | Cancer cell line |
Publications | PubMed=16181800; DOI=10.1016/j.biocel.2005.07.010 PubMed=22436864; DOI=10.1039/c2ib00155a |
Cross-references | |
Cell line databases/resources | cancercelllines; CVCL_A5CT |
Anatomy/cell type resources | BTO; BTO:0006458 |
Encyclopedic resources | Wikidata; Q107115329 |
Entry history | |
Entry creation | 20-May-2021 |
Last entry update | 10-Sep-2024 |
Version number | 6 |